Insights from the RCPE UK consensus conference on approaching the comprehensive management of atrial fibrillation

Expert Review of Cardiovascular Therapy

Volumn 10, Issue 6, 2012, Pages 697-700

  Lip, Gregory Y H ^a   Ramsay, Scott G ^b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b ST JOHN'S HOSPITAL   (United Kingdom)

Author keywords

anticoagulation therapy; aspirin; atrial fibrillation; comprehensive management; consensus conference; screening; stroke prevention

Indexed keywords

ANTICOAGULANT AGENT;

CONFERENCE PAPER; CONSENSUS; ELECTROCARDIOGRAM; EXPECTATION; HEALTH CARE; HEALTH PROGRAM; HEART ATRIUM FIBRILLATION; HEART RATE; HUMAN; MASS SCREENING; MEDICAL SCHOOL; PATIENT ATTITUDE; PATIENT SAFETY; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; STROKE; THROMBOSIS PREVENTION; UNITED KINGDOM;

ANTICOAGULANTS; ATRIAL FIBRILLATION; HUMANS; MASS SCREENING; PRACTICE GUIDELINES AS TOPIC; STROKE; THROMBOSIS;

EID: 84865255500     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/erc.12.48     Document Type: Conference Paper

References (18)

1. Banerjee A, Marín F, Lip GY. A new landscape for stroke prevention in atrial fibrillation: focus on new anticoagulants, antiarrhythmic drugs, and devices. Stroke 42(11), 3316-3322 (2011).
2. Kirchhof P, Lip GY, Van Gelder IC et al. Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options. Executive summary of the report from the 3rd AFNET/EHRA consensus conference. Thromb. Haemost. 106(6), 1012-1019 (2011).
3. Harris K, Edwards D, Mant J. How can we best detect atrial fibrillation? J. R. Coll. Physicians Edinb. 42(Suppl. 18), 5-22 (2012).
4. Camm AJ, Savelieva I. Atrial fibrillation: the rate versus rhythm management controversy. J. R. Coll. Physicians Edinb. 42(Suppl. 18), 23-34 (2012).
5. Lip GYH. What is the most effective and safest delivery of thromboprophylaxis in atrial fibrillation? J. R. Coll. Physicians Edinb. 42(Suppl. 18), 35-44 (2012).
6. Fay M, Montana C. What are the differences between physician and patient expectation with regard to the management of atrial fibrillation? J. R. Coll. Physicians Edinb. 42(Suppl. 18), 45-54 (2012).
7. Liao J, Khalid Z, Scallan C, Morillo C, O'Donnell M. Noninvasive cardiac monitoring for detecting paroxysmal atrial fibrillation or flutter after acute ischemic stroke: a systematic review. Stroke 38(11), 2935-2940 (2007).
8. Lip GY, Tse HF, Lane DA. Atrial fibrillation. Lancet 379(9816), 648-661 (2012).
9. Camm AJ, Kirchhof P, Lip GY et al.; European Heart Rhythm AssociationEuropean Association for Cardio-Thoracic Surgery. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur. Heart J. 31(19), 2369-2429 (2010).
10. Calkins H, Kuck KH, Cappato R et al. 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace 14(4), 528-606 (2012).
11. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 137(2), 263-272 (2010).
12. Lip GY. Anticoagulation therapy and the risk of stroke in patients with atrial fibrillation at 'moderate risk' [CHADS2 score=1]: simplifying stroke risk assessment and thromboprophylaxis in real-life clinical practice. Thromb. Haemost. 103(4), 683-685 (2010).
13. Lip GY. The role of aspirin for stroke prevention in atrial fibrillation. Nat. Rev. Cardiol. 8(10), 602-606 (2011).
14. Olesen JB, Lip GY, Lindhardsen J et al. Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: a net clinical benefit analysis using a 'real world' nationwide cohort study. Thromb. Haemost. 106(4), 739-749 (2011).
15. Lip GY, Andreotti F, Fauchier L et al.; European Heart Rhythm Association. Bleeding risk assessment and management in atrial fibrillation patients. Executive Summary of a Position Document from the European Heart Rhythm Association [EHRA], endorsed by the European Society of Cardiology [ESC] Working Group on Thrombosis. Thromb. Haemost. 106(6), 997-1011 (2011).
16. Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY. A novel userfriendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest 138(5), 1093-1100 (2010).
17. Gallagher AM, Setakis E, Plumb JM, Clemens A, van Staa TP. Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients. Thromb. Haemost. 106(5), 968-977 (2011).
18. Mazzaglia G, Filippi A, Alacqua M et al. A national survey of the management of atrial fibrillation with antithrombotic drugs in Italian primary care. Thromb. Haemost. 103(5), 968-975 (2010).